Thoracic aortic aneurysms (TAA) often represent the final manifestation of hereditary or degenerative disease processes. TAA are primarily caused by age-related degenerative changes. In this article, the authors highlight the most common pathophysiologic mechanisms responsible for TAA formation and review the paucity of evidence supporting the spectrum of medical therapies for TAA other than renin-angiotensin inhibition. More clinical trials on TAA are required before medical therapies such as beta-blockers, statins, and macrolide antibiotics can be recommended.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccl.2010.01.002DOI Listing

Publication Analysis

Top Keywords

thoracic aortic
8
aortic aneurysms
8
medical therapies
8
taa
5
medical therapy
4
therapy thoracic
4
aneurysms work?
4
work? beta-blockers
4
beta-blockers indicated?
4
indicated? con
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!